Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Total 13F shares
-
28,825,281
-
Share change
-
+24,165
-
Total reported value
-
$614,994,160
-
Price per share
-
$21.31
-
Number of holders
-
158
-
Value change
-
-$34,839
-
Number of buys
-
70
-
Number of sells
-
72
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2014
As of 30 Sep 2014,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
158 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,825,281 shares.
The largest 10 holders included
Bank of New York Mellon Corp, Broadfin Capital, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., LOOMIS SAYLES & CO L P, GUGGENHEIM CAPITAL LLC, and FIDUCIARY MANAGEMENT ASSOCIATES LLC.
This page lists
158
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.